Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus
- 1 March 1985
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 34 (3) , 379-386
- https://doi.org/10.1016/0090-1229(85)90186-2
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.Journal of Clinical Investigation, 1983
- Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.Journal of Clinical Investigation, 1983
- Acid-Labile Human Leukocyte Interferon in Homosexual Men with Kaposi's Sarcoma and LymphadenopathyThe Journal of Infectious Diseases, 1982
- Cytotoxic antibodies to natural killer cells in systemic lupus erythematosusClinical Immunology and Immunopathology, 1982
- Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1982
- Natural killing in systemic lupus erythematosus: Inhibitory effects of serumClinical Immunology and Immunopathology, 1980
- Immune Interferon in the Circulation of Patients with Autoimmune DiseaseNew England Journal of Medicine, 1979
- SYSTEMIC LUPUS ERYTHEMATOSUS AND LYMPHOMAThe Lancet, 1978
- Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.Journal of Clinical Investigation, 1976
- Malignancy in a series of 70 patients with systemic lupus erythematosusArthritis & Rheumatism, 1974